Skip to Main Content

Paper Details

Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1.
0
2023
AZD9574, HRD, HRR, HRR-deficiency, MGMT, Mouse, O6-methylguanine, O6-methylguanine-DNA methyltransferase, PARP, PARP1, TMZ, anti, brain tumors, cancer, cancer cell, glioma, mice, monkey, mouse, primary and secondary, rat, temozolomide, tumor

Datasets

Release 1.2